TSLL has declined approximately 32% over the past 30 days, driven by a sharp selloff in TSLA following disappointing Q2 2026 earnings. Over the last quarter, the leveraged ETF has fallen roughly 36%, reflecting persistent headwinds for Tesla shares and the compounding effect of 2x daily leverage in a declining market.

NVDL provides 2x daily leveraged exposure to NVDA , the world's largest semiconductor company by market capitalization, currently valued at approximately $5 trillion. The ETF has posted a modest recovery of roughly 6.6% over the past 30 days, reflecting NVIDIA's stabilization around the $200 level after pulling back approximately 17% from its May 2026 all-time high.

Union Pacific delivered a strong double beat for the second quarter of 2026, reporting adjusted diluted earnings per share (EPS) of $3.41 versus consensus estimates of approximately $3.23, and operating revenue of $6.86 billion against expectations of roughly $6.72 billion. Freight revenue reached an all-time quarterly record of $6.52 billion, rising 12% year-over-year on higher volumes, pricing gains, and fuel surcharge revenue.

SAP missed Wall Street estimates: Non-IFRS (non-International Financial Reporting Standards) adjusted earnings per American Depositary Receipt came in at $1.82, below the $2.03 consensus, while revenue of $11.28 billion fell short of the $11.44 billion forecast. Cloud momentum remained exceptional: Cloud revenue rose 24% at constant currencies to €6.28 billion, and current cloud backlog jumped 26% at constant currencies to nearly €22.9 billion, accelerating from the first quarter.

Revenue topped expectations: Thermo Fisher Scientific reported Q2 2026 revenue of $11.99 billion, up 10% year over year and ahead of the consensus estimate of approximately $11.71 billion. Adjusted EPS surged past forecasts: Adjusted earnings per share (EPS) came in at $6.03, a 13% increase from the prior-year period and comfortably above analyst expectations of roughly $5.72.

T-Mobile reported adjusted earnings of $2.99 per share , comfortably surpassing consensus estimates of approximately $2.55–$2.59. Revenue came in at $22.79 billion , up 7.9% year over year but narrowly missing the Street forecast of roughly $22.95 billion.

ConnectOne Bancorp reported adjusted earnings of $0.84 per share for the second quarter of 2026, topping the consensus analyst estimate of $0.82, while revenue of $121.57 million came in essentially in line with expectations. Net interest margin (NIM) expanded for the seventh consecutive quarter , reaching 3.42%, driven by the ongoing repricing of adjustable-rate loans at higher rates.

Carter Bankshares reported Q2 2026 GAAP diluted earnings per share (EPS) of $1.31, driven by a $35.9 million pre-tax gain from the sale of its Bearing Insurance Group membership interest. Adjusted EPS of $0.53 fell short of consensus estimates, as core operating profitability came in below analyst expectations.

Revenue missed consensus: Q4 revenue of $476.1 million fell roughly 7.9% below analyst estimates of approximately $517 million, declining 6% year-over-year. Adjusted EPS matched expectations: Adjusted diluted earnings per share came in at $2.19, precisely in line with Wall Street consensus, more than doubling from $0.87 a year ago.

Q2 2026 diluted earnings per share (EPS) of $1.04 beat the consensus analyst estimate of $0.93 by $0.11, marking a 22.4% increase from $0.85 in the same quarter last year. Net income available to common shareholders rose 21.3% year-over-year to $20.8 million, driven by record net interest income of $53.4 million and sustained expense discipline.

Revenue surged 25% year-over-year to $16.1 billion, exceeding the consensus estimate of $14.43 billion by approximately $1.7 billion. Non-GAAP earnings per share (EPS) of $0.42 came in well above the $0.22 analyst consensus, marking a swing from a loss of $0.10 per share in the year-ago quarter.

RTX Corporation reported Q2 2026 adjusted earnings per share (EPS) of $1.89 , handily beating the Wall Street consensus estimate of $1.66 by $0.23, a 13.9% positive surprise. Revenue reached $24.7 billion, up 14% year-over-year and 16% organically , exceeding analyst expectations of approximately $22.88 billion by nearly $1.8 billion.

VDE surged approximately 11% over the past 30 days, driven by a sharp rally in crude oil prices that pushed Brent above $100 per barrel and WTI near $92. Escalating geopolitical tensions in the Middle East — including Houthi attacks on Saudi oil tankers in the Red Sea and renewed U.S.-Iran hostilities — injected a substantial risk premium into energy markets.

PBR shares surged approximately 11.5% over the last 30 days, climbing from $17.03 on June 23 to $18.99 as of July 23, 2026, fueled by escalating Middle East geopolitical tensions and a sharp rally in crude oil prices. Brent crude rebounded roughly 27% from its early-July lows near $71.57 per barrel, driven by renewed US-Iran hostilities, Houthi attacks on Saudi-linked tankers in the Red Sea, and disruptions in the Strait of Hormuz.

BP shares surged approximately 11.7% over the last 30 days, rising from a closing price of $39.33 on June 23 to $43.94 as of July 23, 2026. The rally was fueled by escalating Middle East tensions that disrupted Strait of Hormuz shipping routes, driving Brent crude to average $103.85 per barrel in the second quarter — a sharp jump from $81.13 in Q1.

Canadian Natural Resources (CNQ) surged approximately 14.7% over the past 30 days, climbing from $41.02 on June 23 to $47.03 as of July 23, 2026, supported by a six-session winning streak. The rally was fueled by a rebound in crude oil prices tied to escalating U.S.-Iran tensions and the closure of the Strait of Hormuz, which disrupted nearly 20% of global oil supply flows.

MBLY plunged -15.95% during the regular session to $7.38, after an initial -5% premarket selloff following its Q2 2026 earnings release and a major leadership announcement. Founder and CEO Amnon Shashua announced he will step down after 27 years once a successor is found, injecting significant uncertainty with no immediate replacement identified.

EVH plunged -13.64% during regular trading Thursday, dropping from a prior close of $5.57 to an intraday low near $4.81, marking its steepest single-day decline in months. Citigroup analyst Daniel Grosslight downgraded Evolent Health from Buy to Sell, citing a less favorable risk/reward after the stock rallied more than +100% over the prior three months.

LBRT plunged -15.63% during regular trading hours to $21.21, erasing value despite a broader surge in oil prices driven by escalating U.S.-Iran hostilities. The sell-off is a direct reaction to Q2 2026 earnings released after the July 22 close: revenue beat at $1.2B (+14% YoY), but adjusted EPS of $0.09 declined -25% from $0.12 a year ago.

GFUZ tumbled -16.02% during regular trading Thursday, sinking to $6.92 from a prior close of $8.24, extending its relentless post-SPAC collapse now entering its second week. The stock has shed roughly 46% from its July 13 debut close of $11.00, as the initial first-day trading frenzy that briefly sent shares above $14 gives way to sustained selling pressure.